학술논문
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry
Document Type
Article
Author
Karadag, O.; Farisogullari, B.; Kilic, L.; Coskun, B.N.; Kiraz, S.; Ertenli, I.; Kalyoncu, U.; Yagiz, B.; Pehlivan, Y.; Dalkilic, E.; Erden, A.; Kucuksahin, O.; Ademoglu, Z.; Emmungil, H.; Kimyon, G.; Sule Bilge, N.; Kasifoglu, T.; Cemal Icacan, O.; Bes, C.; Ersozlu, E.D.; Mercan, R.; Koca, S.S.; Gonullu, E.; Cinar, M.; Akar, S.; Omma, A.
Source
In: Clinical and Experimental Rheumatology . (Clinical and Experimental Rheumatology, January 2024, 42(1):130-137)
Subject
Language
English
ISSN
1593098X
0392856X
0392856X